2 studies found for:    11504744 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases
Condition: Melanoma
Interventions: Drug: Vemurafenib;   Drug: Cobimetinib
2 Terminated
Has Results
Drosophila-generated CTL
Condition: Metastatic Cutaneous Melanoma
Interventions: Drug: fludarabine;   Drug: cyclophosphamide;   Drug: Drosophila-peptide pulsed Melanoma-reactive autologous CD8+ PBL;   Drug: Aldesleukin

Indicates status has not been verified in more than two years